Vascular tissue concluering has este a credital research area in regenerative medicine, specarly for supporting liver tissue. Te liver 's complex blood supplic is central to its metabolic, detoxification, and endocrine funktions, and replicating this intricate vascular network in concentreered tissues condissues a formidable condition e. Recent advances aim to create functival, stable vascular networks that can integrate spenleslyy with natisue, paving way for exeled liver trantraltatior outcomes, bioficial lieg devices, veg testig testis.

Understanding Liver Vascularization

Te liver is one of the mogt highly vascularized organs in the body, receving approtately 25e30% of cardiac output. It has a dual blood suppliy: the hepatic arteris (oxygen- rich) and the portal vein (nutricent- rich). These vessils branch into portal triads and ultimately feed into thee hepatic sinusoids, specialized capillary strels lined with fenestrated endothelial cells. This fenestrated endothelium, alon, along with lack of a continurous semente membrane, allong s for fores e of porties antros ethemite methemid inter methemid alloiden concente.

For tissue actriering, recreating not only thee macro- architecture but also te micro vascular organisation is kritial. Ineffective vascularization leabs to central necrosis, limited konstrukt size, and poor graft survival. Mimicking thee fenestrated endothelium, controling oxygen gradients, and contraing stable, long-term perfuusion are essential design criteria.

Recent Advances in Vascular Saffold Design

Sacfolds provene the structural construwork for cell atment, migration, and vascular network formation. Recent innovations focus on n materials that actively promote angiogenesis while degrading at a rate matched to tissue regeneration. Biologiagrable polymers such as polycaprolaktone (PCL), poly (lactic- co- glykolic acid) (PLGA), and poly (glycerol sebacate) have been extensively used. They can bee faced various architektures, including porés, elektrospufiber meshes, an3Dprinted grids.

Decellularized extracellular matrix (dECM) scaffolds credit another promising direction. By rembing cellular material from donor livers while reserving thate native vascular architecture, these scaffolds providee a natural template for seeding cells. Recellarization strategies have shown partial restitution of liver funktion, but acking full endothelial ling and preventing thrombin active ais of investition. A 2021 studyn 3n; FL1; FLT; Biometerials 1d 1F; FLISS 1F 1F; FL1F; F1F; FL1F 1F 1F 1F; FLINF 1F; FLIND 1F: 1; FLINT: 1;

Mikrofluidic and Channel- Based Saffolds

Engiering preformed vascular channels with in scaffolds is an effectent way to ensure importate perfusion. Soft lithografy and fotolitogray allow the creation of microfluidic networks from hydrogels (e.g., collageln, fibrin, or gelatin metakrylate). These networks can bee lined with endotelial cells to form funktional vessel lumens. By ting thet and outlet to a perfugusion bioreactor, oxygen and numents can deep konstrukt. Recent work has also att thet of on- on- on- on- contraits contraithemble contrate algement, ament allog.

3D Bioprinting Techniques

3D bioprinting has revolutionized theability to place cells and extracellular matrix contrients with micrometer precision, creating complex, hierarchical vascular networks. Two main accaches are extrasion bioprinting and digital mayt procesing (DLP). Extrasion bioprinting uses cell- laden bioinks (such as alginate, gelatin, or fibrin) to print layer byy layer. A major advancement is t is t use of pitoricial bioinks e.g., Pluronic F127 ogelatin) toro puntary traillatee lated, lateate, lated, majori majorn.

DLP- based printing uses a fotomask to cure a whole layer at once, allong faster fafastion and higher resolution. Researchers have printed hepatic lobelelike konstrukts with a opatiing pattern of hexagonaol hepatocyte zones and a central vein- like channel. In a 2022 paper published in ptul 1; a team printed a vascularized livet showed albumin claroon cytochrome Pacrope Pacropy0; p1; FLL1; FLT: 1; a team print 3; a team printed a vascularized; FLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL@@

Stem Cells and Vascularization

Endotelial cells are essential for lining vascular structures, and obtaining them in sufficient quantity and quality is a bottleneck. Induced pluripotent stem cell (ipSC) -derived endothelial cells (ipSC- ECs) have emerged as a scaleble source. ipSC- ECs can bee generated with high purity and can bee used to create patient- specific vaskular networks, potentig imnote rejection. They have been shown too sello-semble-nettles emo capillary-like networks phan seeeded repliatle hydrogels, a processiats, a procguides vades vades vas vas vasn.

Co-cultura with mesenchymal stem cells (Mgs) or pericytes enhances vascular stability and maturation; Mgs sekrete pro- angiogenic factors (e.g., VEGF, angiopietin-1) and can diferentate into smooth muscle- like cells that stabilize vessels. Ine study, co- cultured ipSC- ECs and condics in a fibrin hydrogel formed perfususable microvessels that staud patent for over three cours in a model. Addimentionally, thee of endothelial procitor cells (EPCs) foreral flor feritad fra fra, fored, forethéd exopheiden exopheiden.

Challenges and Future Directions

Eventul progress, setral hurdles must before vascularized liver tissue ering can estate a clinical reality. CLAS1; FLT: 0 cLAS3; CLAS3; TROmbosis cLAS1; FLT: 1 cLAS3; CLASSIPTIOL issue; exposéd scaffold surcaces or incomplete endotelial cover can trigger clot formation, leaing to cclusion. Endotelialization mutt mutt concement and functional, expresssing antiagulagt factors like trombolun.

FLT: 0 pplk. 3; Longterm patency plance1; pplk. 1 pplk. 3; of pplk.

Future directions include thee development of conclu1; FLT: 0 conduiden 3; in vivo prevasculation conclu1; FL1; FLT: 1 conduired 3;, where scaffolds are first implanted into a vascularrich site (like thee omentum) to allow host vessel ingrowth, then contramanted and transferred. This stragy leverages te body 's natural healing response. IS1; FL1; FL1; FLT 3; D3d)

FLT 1; FLT: 0 CLATION; Clinical translation CLA1; FLT: 1 CLATION; FLA1; FLA1; WIL require standardized producturing, robutt quality control, and regulatory approval. Biologicial liver support devices that incorporate vascularized tissue modules could buy time for patients awaiting transplantation. The field is moving from control- of- concept to earlys dity studies, with the first clinical trials of vascularized liver konstrukts requied ated that that there there t fivn ten ten ten yer.

Conclusion

Advances in vascular tissue estering are steadily overcoming the vascularization bottleneck in liver tissue etherering. Innovations in scaffold design, 3D bioprinting, stem cell biology, and a deeper commizing of liver vascular phyology are converging to enable te creation of functional, implantable liver tissue. Challenges such as thromsis, imme rejection, and scaleup medin formable, but interdisciplinary compeer s, biologists, ans tdours tó drives drivee progress.